Vanderbilt University Medical Center

Based in TN

🤖

AI Overview

With $1.8M in lobbying spend across 33 quarterly filings, Vanderbilt University Medical Center is a significant lobbying presence. Their lobbying covers 12 issue areas. Active from 2018 to 2025.

$1.8M
Total Spend
8
Years Active
1
Firms Hired
2
Lobbyists Deployed
12
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$455K
2019$160K
2020$120K
2021$130K
2022$150K
2023$160K
2024$260K
2025$320K

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Vanderbilt University Medical Center disclosed contacting in their lobbying filings.

Health & Human Services, Dept of (HHS)HOUSE OF REPRESENTATIVESSENATEOffice of the Vice President of the United StatesSubstance Abuse & Mental Health Services Administration (SAMHSA)Education, Dept ofCenters For Medicare and Medicaid Services (CMS)Homeland Security, Dept of (DHS)Office of Science & Technology Policy (OSTP)Executive Office of the President (EOP)Health Resources & Services Administration (HRSA)Food & Drug Administration (FDA)Office of Management & Budget (OMB)White House Office
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Pharmacy, MED, Budget/Appropriations and 7 more

Issues related to FY 19 funding for HRSA programs.

Issues related to FY 18 and FY 19 funding for the CDC, including public health and global health programs.

S.1022/H.R.880, the MISSION ZERO Act, is

H.R. 4392, addressing OPPS cuts to certain 340B hospitals.

Issues related to a Medicare national coverage decision on Next Generation Sequencing.

General issues related to Graduate Medical Education

H.R. 4392, addressing OPPS cuts to certain 340B hospitals.

Issues related to the 340B discount drug program.

Issues related to drug shortages, including related FDA and DEA policies.

H.R. 1625, the Consolidated Appropriations Act of 2018.

H.R.5092/S.2438, the Flue Vaccine Act.

Issues related to FY 18 funding for NIH.

Issues related to FY 19 funding for NIH.

H.R.1892, the Bipartisan Budget Act of 2018.

H.R. 1625, the Consolidated Appropriations Act of 2018.

Issues related to FY 18 funding for NIH.

Issues related to FY 18 funding for the CDC.

Issues re

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.